Currently, there are 184.04M common shares owned by the public and among those 122.26M shares have been available to trade.
Insiders at the company have transacted a total of 0 times over the past 12 months, according to data filed with the U.S. Securities and Exchange Commission (SEC). 0 of these insider trades were purchases, accounting for 0 shares. Insider sales of the common stock occurred on 0 occasions, with total insider shares sold totaling 0 shares.
The company’s stock has a 5-day price change of 2.44% and 18.78% over the past three months. ALGM shares are trading 17.20% year to date (YTD), with the 12-month market performance down to -16.79% lower. It has a 12-month low price of $18.59 and touched a high of $33.26 over the same period. ALGM has an average intraday trading volume of 2.39 million shares. The stock is trading above its simple moving averages at the SMA20, SMA50, and SMA200, as the current price level is off by 3.82%, 7.85%, and 5.13% respectively.
Institutional ownership of Allegro Microsystems Inc (NASDAQ: ALGM) shares accounts for 77.32% of the company’s 184.04M shares outstanding.
It has a market capitalization of $4.72B and a beta (3y monthly) value of 1.67. The earnings-per-share (ttm) stands at -$0.34. Price movements for the stock have been influenced by the stock’s volatility, which stands at 8.24% over the week and 6.27% over the month.
Earnings per share for the fiscal year are expected to decrease by -83.03%, and 128.82% over the next financial year. EPS should shrink at an annualized rate of -10.58% over the next five years, compared to 11.89% over the past 5-year period.
Looking at the support for the ALGM, a number of firms have released research notes about the stock. Wells Fargo stated their Overweight rating for the stock in a research note on November 22, 2024, with the firm’s price target at $23. Loop Capital coverage for the Allegro Microsystems Inc (ALGM) stock in a research note released on November 12, 2024 offered a Buy rating with a price target of $30. Morgan Stanley was of a view on November 07, 2024 that the stock is Equal-Weight, while UBS gave the stock Buy rating on September 03, 2024, issuing a price target of $33. Jefferies on their part issued Buy rating on May 13, 2024.
